Clinical characteristics affect the impact of an uninformative DNA test result: The course of worry and distress experienced by women who apply for genetic testing for breast cancer

78Citations
Citations of this article
56Readers
Mendeley users who have this article in their library.

Abstract

Purpose: DNA mutation testing for breast cancer usually yields an uninformative result, which is a negative result in the absence of a known BRCA mutation within the family. However, few data are available on the psychological impact of this result. Moreover, the clinical heterogeneity within this group has not yet been considered. This study provides prospective data about the course of cancer-specific worry and distress for different groups of test applicants. Patients and Methods: All DNA test applicants (n = 238) completed three questionnaires: before and 1 and 7 months after disclosure of a DNA mutation test. With repeated-measures analysis of variance, differences were assessed between BRCA 1/2-positive women (n = 42), BRCA 1/2-true-negative women (n = 43), and women with an uninformative test result (n = 153). Results: On the group level, women with an uninformative result seemed to be reassured after disclosure (P < .001), but to a lesser extent than those women who received a true-negative result. However, not all women with an uninformative result reacted similarly: higher levels of worry and distress could be explained by relatively straightforward clinical variables, namely a personal history of cancer (P ≤ .001) and a higher pedigree-based risk (P ≤ .005). Furthermore, these clinical variables determined whether these women were either comparable to women who received a true-negative result or to BRCA mutation carriers. Conclusion: Women with an uninformative result form a heterogeneous group of test applicants. The subpopulation of those with both a personal history of cancer and a relatively high pedigree-based risk expressed the highest levels of worry 7 months after DNA testing. © 2006 by American Society of Clinical Oncology.

References Powered by Scopus

Impact of event scale: A measure of subjective stress

6708Citations
N/AReaders
Get full text

Autosomal dominant inheritance of early‐onset breast cancer. Implications for risk prediction

880Citations
N/AReaders
Get full text

Statement of the American Society of Clinical Oncology: Genetic Testing for Cancer Susceptibility

695Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA -Related Cancer: US Preventive Services Task Force Recommendation Statement

355Citations
N/AReaders
Get full text

Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: A systematic review to update the U.S. preventive services task force recommendation

212Citations
N/AReaders
Get full text

Emotional Distress Following Genetic Testing for Hereditary Breast and Ovarian Cancer: A Meta-Analytic Review

194Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

van Dijk, S., Timmermans, D. R. M., Meijers-Heijboer, H., Tibben, A., van Asperen, C. J., & Otten, W. (2006). Clinical characteristics affect the impact of an uninformative DNA test result: The course of worry and distress experienced by women who apply for genetic testing for breast cancer. Journal of Clinical Oncology, 24(22), 3672–3677. https://doi.org/10.1200/JCO.2005.03.7259

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 32

78%

Professor / Associate Prof. 5

12%

Researcher 3

7%

Lecturer / Post doc 1

2%

Readers' Discipline

Tooltip

Psychology 17

44%

Medicine and Dentistry 11

28%

Biochemistry, Genetics and Molecular Bi... 6

15%

Agricultural and Biological Sciences 5

13%

Save time finding and organizing research with Mendeley

Sign up for free